Cargando…
Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours
The aim of this study was to establish the criteria for methodology of cellular “anti-IGF-I” therapy of malignant tumours and particularly for glioblastoma multiforme. The treatment of primary glioblastoma patients using surgery, radiotherapy, and chemotherapy was followed by subcutaneous injection...
Autores principales: | Trojan, Jerzy, Pan, Yuexin X., Wei, Ming X., Ly, Adama, Shevelev, Alexander, Bierwagen, Maciej, Ardourel, Marie-Yvonne, Trojan, Ladislas A., Alvarez, Alvaro, Andres, Christian, Noguera, Maria C., Briceno, Ignacio, Aristizabal, Beatriz H., Kasprzak, Heliodor, Duc, Huynh T., Anthony, Donald D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287029/ https://www.ncbi.nlm.nih.gov/pubmed/22400112 http://dx.doi.org/10.1155/2012/721873 |
Ejemplares similares
-
Erratum to “Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours”
por: Trojan, Jerzy, et al.
Publicado: (2012) -
Rescue of MHC-1 Antigen Processing Machinery by Down-Regulation in Expression of IGF-1 in Human Glioblastoma Cells
por: Pan, Yuexin, et al.
Publicado: (2013) -
Joint Evolutionary Trees: A Large-Scale Method To Predict Protein
Interfaces Based on Sequence Sampling
por: Engelen, Stefan, et al.
Publicado: (2009) -
IGF-1R as an anti-cancer target—trials and tribulations
por: Chen, Helen X., et al.
Publicado: (2013) -
Consilium Smartphone App for Real-World Electronically Captured Patient-Reported Outcome Monitoring in Cancer Patients Undergoing anti-PD-L1-Directed Treatment
por: Trojan, Andreas, et al.
Publicado: (2020)